The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Jin, Jianmin ^a   Liu, Xiaofang ^a   Sun, Yongchang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Allergy; Aspergillus; Chronic obstructive pulmonary disease; Immunoglobulin E

Indexed keywords

IMMUNOGLOBULIN E; BIOLOGICAL MARKER;

ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SENSITIZATION; SMOKING HABIT; SYMPTOMATOLOGY; VERY ELDERLY; WHEEZING; ASPERGILLUS; BLOOD; CROSS-SECTIONAL STUDY; LUNG; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; AGED, 80 AND OVER; ASPERGILLUS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84927788455     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-014-0130-1     Document Type: Article

References (37)

1. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ: Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, 182: 598-604. 10.1164/rccm.200912-1843CC.
2. Jamieson DB, Matsui EC, Belli A, McCormack MC, Peng E, Pierre-Louis S, Curtin-Brosnan J, Breysse PN, Diette GB, Hansel NN: Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013, 188: 187-192. 10.1164/rccm.201211-2103OC.
3. Agarwal R, Agarwal AN, Gupta D, Jindal SK: Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009, 13: 936-944.
4. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK: Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?. Med Mycol. 2010, 48: 988-994. 10.3109/13693781003743148.
5. Bafadhel M, McKenna S, Agbetile J, Fairs A, Desai D, Mistry V, Morley JP, Pancholi M, Pavord ID, Wardlaw AJ, Pashley CH, Brightling CE: Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 2014, 43: 64-71. 10.1183/09031936.00162912.
6. Hakonarson H, Carter C, Kim C, Grunstein MM: Altered expression and action of the low- affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. J Allergy Clin Immunol. 1999, 104: 575-584. 10.1016/S0091-6749(99)70326-X.
7. Redhu NS, Saleh A, Lee HC, Halayko AJ, Ziegler SF, Gounni AS: IgE induces transcriptional regulation of thymic stromal lymphopoietin in human airway smooth muscle cells. J Allergy Clin Immunol. 2011, 128: 892-896. 10.1016/j.jaci.2011.06.045.
8. Redhu NS, Shan L, Al-Subait D, Ashdown HL, Movassagh H, Lamkhioued B, Gounni AS: IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways. Allergy Asthma Clin Immunol. 2013, 9: 41-50. 10.1186/1710-1492-9-41.
9. Roth M, Zhong J, Zumkeller C, S'ng CT, Goulet S, Tamm M: The role of IgE-receptors in IgE-dependent airway smooth muscle cell remodelling. PLoS One. 2013, 8: e56015-10.1371/journal.pone.0056015.
10. Celli BR, Barnes PJ: Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007, 29: 1224-1238. 10.1183/09031936.00109906.
11. Nishimurak K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002, 121: 1434-1440. 10.1378/chest.121.5.1434.
12. Agarwal R, Maskey D, Aggarwal AN, Saikia B, Garg M, Gupta D, Chakrabarti A: Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One. 2013, 8: e61105-10.1371/journal.pone.0061105.
13. Schwartz HJ, Greenberger PA: The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med. 1991, 117: 138-142.
14. Mahdavinia M, Grammer LC: Management of allergic bronchopulmonary aspergillosis: a review and update. Ther Adv Respir Dis. 2012, 6: 173-187. 10.1177/1753465812443094.
15. Gottlieb DJ, Sparrow D, O'Connor GT, Weiss ST: Skin test reactivity to common aeroallergens and decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med. 1996, 153: 561-566. 10.1164/ajrccm.153.2.8564098.
16. Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, Hirota T, Tamari M, Hizawa N: Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes. Int J Chron Obstruct Pulmon Dis. 2011, 6: 181-189.
17. Frew AJ, Kennedy SM, Chan-Yeung M: Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations. Am Rev Respir Dis. 1992, 146: 878-883. 10.1164/ajrccm/146.4.878.
18. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA: Methacholine predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996, 153: 1802-1811. 10.1164/ajrccm.153.6.8665038.
19. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, Moss R, Denning DW: Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013, 43: 850-873. 10.1111/cea.12141.
20. O'Connor GT, Sparrow D, Weiss ST: The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989, 140: 225-252. 10.1164/ajrccm/140.1.225.
21. Agarwal R, Chakrabarti A: Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol. 2013, 8: 1463-1474. 10.2217/fmb.13.116.
22. Chakrabarti A, Sethi S, Raman DS, Behera D: Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses. 2002, 45: 295-299. 10.1046/j.1439-0507.2002.00738.x.
23. Newby C, Agbetile J, Hargadon B, Monteiro W, Green R, Pavord I, Brightling C, Siddiqui S: Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma.J Allergy Clin Immunol 2014, in press.
24. Zedan M, Attin G, Zedan MM, Osman A, Abo-Elkheir N, Maysara N, Barakat T, Gamil N: Clinical asthma phenotypes and therapeutic responses.ISRN Pediatr 2013, 824781. , [ http://dx.doi.org/10.1155/2013/824781 ]
25. Bourdin A, Serre I, Flamme H, Vic P, Neveu D, Aubas P, Godard P, Chanez P: Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice?. Thorax. 2004, 59: 488-493. 10.1136/thx.2003.016899.
26. Vroling AB, Duinsbergen D, Fokken WJ, van Drunen CM: Allergen induced gene expression of airway epithelial cells shows a possible role for TNF-alpha. Allergy. 2007, 62: 1310-1319. 10.1111/j.1398-9995.2007.01495.x.
27. Tsai JJ, Liao EC, Hsu JY, Lee WJ, Lai YK: The differences of eosinophil- and neutrophil-related inflammation in elderly allergic and non-allergic chronic obstructive pulmonary disease. J Asthma. 2010, 47: 1040-1044.
28. Liu XF, Sun YC, Jin JM, Li R, Liu Y: Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 3 cases. Zhonghua Jie He He Hu Xi Za Zhi. 2013, 36: 741-745.
29. Mir E, Shah A: Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Prim Care Respir J. 2012, 21: 111-114. 10.4104/pcrj.2012.00001.
30. Agarwal R, Srinivas R, Jindal SK: Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses. 2007, 51: 83-85.
31. Simpson JL, Powell H, Baines KJ, Milne D, Coxson HO, Hansbro PM, Gibson PG: The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial. PLoS One. 2014, 9: e105609-10.1371/journal.pone.0105609.
32. Bade G, Khan MA, Srivastava AK, Khare P, Solaiappan KK, Guleria R, Palaniyar N, Talwar A: Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014, 9: 759-773.
33. de Deus CR, Chiarion Sassi F, Davison Mangilli L, Jayanthi SK, Cukier A, Zilberstein B, de Andrade CR F: Swallowing transit times and valleculae residue in stable chronic obstructive pulmonary disease. BMC Pulm Med. 2014, 14: 62-10.1186/1471-2466-14-62.
34. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.
35. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.
36. Wouters EF: The burden of COPD in the Netherlands: results from the Confronting COPD survey. Respir Med. 2003, 97: S51-S59. 10.1016/S0954-6111(03)80025-2.
37. Global initiative for chronic obstructive pulmonary disease, globle strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, updated 2014. [], [ http://www.goldcopd.org ]